our structure
The organisational structure of CRCBID comprises a Board of Directors, sub Committees responsible for specific sectoral oversight, an executive team, and a management team that conducts the company's business.
Board
The Board of Directors comprises an independent chairman, three independent directors and nominees from each of the industry and research participants of CRCBID. The Directors are responsible for corporate governance and oversight of the strategic direction of CRCBID, including the alignment of objectives and activities, and the identification of risks.The Board meets every two months.
Executive Team
The Executive Team comprises a Chief Executive Officer and representatives of participating organisations. The representatives are usually also directors of CRCBID. The Team is responsible for the operation and management of CRCBID.
Audit, Finance, Risk and Remuneration Committee
This committee reviews CRCBID's financing and external reporting and ensures compliance with applicable laws, regulations and CRCBID's Commonwealth Agreement. It also monitors the internal safeguards against conflicts of interest, fraud and assesses various management processes. The committee meets formally at least three times a year with an independent director as its chair.
Clinical Trials and Commercialisation Committee
This committee manages issues relating to CRCBID clinical trials, CRCBID's intellectual property assets, including its protection, use and commercialisation, and ensures that CRCBID's activities do not infringe the intellectual property of others. The committee meets formally at least three times a year.
Project Management Committee
This committee works in conjunction with the Clinical Trials and Commercialisation Committee to ensure CRCBID's research projects are conducted to the highest standards and that the technical risks associated with each project are properly identified and understood.
